Seroxat, Paxil and Other Dirty Glaxo Secrets…

Just thought I would demonstrate to my blog readers the kind of stuff that GSK get up to. All of the following documents have been stored online by POGO, and they are all mainly from GSK litigation trials (Paxil in the US). It really is a remarkable resource for anyone who wishes to gain insight into what goes on in the GSK world. This pharmaceutical company would literally do anything for profit. Some of the documents are quite shocking.

This document is from one of the trials against GSK for fraudulent promotion of Paxil (seroxat). It gives a list of the Doctors whom the drug reps intend to target with gifts, money and enticements.
These psychiatrists and doctors were willingly recruited by GSK in order to make them prescribe Paxil above the competing SSRI’s.

Produced By GSK In Cunningham v. GSK (U.S.D.C., N.D. Ind.)
P AR041026956
Consultant Rasource IVlanuaJ
This booklet is provided to you as a guide to help plan PsychNet programs in your region. PsychNet: Paxil® Clinicians Speaker Council provides trained physician speakers for programs in each region. PsychNet is a new resource for all consultants to use for dinner programs, round tables or any speaker engagement (excluding CME such as CD Rounds: Hidden Diagnosis). PsychNet physicians have ail been educated on the benefits of Paxil® (paroxetine HCI) and its
effective treatment on mood and anxiety disorders.

PsychNet: Paxil® Clinicians Speaker Councils one of many physician programs the Paxilteam has developed for 2000 to engender solid relationships with influential physicians in each region. The goals of the program are to:
o Develop and/or solidify relationships with key influential psychiatrists and primary care physicians
o Develop these physicians into knowledgeable and engaging speakers on Paxil and its effective treatment on mood and anxiety disorders
° Build advocacy amongst PsychNet physicians by creating speaking opportunities
PsychNet is an ideal way for key opinion leaders to influence clinicians in your region on the benefits of Paxil versus competitors.

PsychNet Speakers – Selection and Training
Each region selected several physicians who are influential in their com- munities, credible and interested in speaking on behalf of Paxil. Specifically, the physicians met the following criteria:
o Local key opinion leaders o Educated on the benefits of Paxil o Strong communication skills
A list of regional speakers can be found at the back of this booklet
Produced By GSK In Cunningham v. GSK (U.S.D.C., N.D. Ind.)
Produced By GSK In Cunningham v. GSK (U.S.D.C., N.D. Ind.)
P AR041026958
Each physician was invited to a weekend training session and educated on the efficacy of Pax/land the PsychNet presentations. The PsychNet Advisory Board reviewed all of the presentations and were closely involved with the training process.
The PsychNet Advisory Board includes: Daniel D. Christensen, MD, Clinical Professor of Psychiatry, Clinical Professor of Neurology Adjunct Professor of Pharmacology, Neuropsychiatry Institute, University of Utah
Prakash S. Masand, MD, Professor of Psychiatry, Director, Psychopharmacology Consultation, Training, and Research Program, SUNY Upstate Medical University
Peter J. Panzarino, MD, Chairman, Department of Psychiatry, Cedars-Sinai Medical Center
David V. Sheehan, MD, MBA, Professor of Psychiatry, University of South Florida College of Medicine, Director, Clinical Research
Guest Speakers at Training Session: CharlesNemeroff,MD,PhD,ReunetteW.HarrisProfessorandChairman, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine
Rajinder Kumar, MD, Vice President and Director Neurosciences Clinical Research, Development and Medical Affairs of North America, SmithKline Beecham Pharmaceuticals
PsychNet Presentations and Slide Kits
Each PsychNet speaker has been trained on a total of 5 presentations. The PsychNet speaker has been provided with 35 MM slides and CD-ROMs with the following five Power Point presentations:
G Contemporary Issues in Depression – Discusses major depression, SSRI treatment, the efficacy of Paxil in treating depression versus other SSRI/SNRls, and briefly discusses the serotonin/norepinephrine dual action effect of?axil.
• Contemporary Issues in Anxiety Spectrum Disorders – Reviews the prevalence of anxiety spectrum disorders, current treatment options and the efficacy of Paxil to treat anxiety.
* Antidepressants and Managed Care: Issues and Solutions- Discusses the efficacy of Paxil in treating mood and anxiety disorders and the importance of treating these disorders and reviews the cost of treatment ofSSRIs.
3 The Role of Norepinephrine in Depression -A high science presenta- tion that identifies the theory of NET and 5-HT neurotransmitters, reviews the roles of each, and discusses the potential norepinephrine effect of Paxil at higher dosages.
° Controversial Issues in SSRI Therapy: A Critical Review – Highlights the importance of understanding clinical data and looks at issues that affect all SSRIs such as weight gain, sexual dysfunction, drug interac- tion and discontinuation.
PsychNet speaker slide kits also have a Q&A section. This section contains additional data on PTSD, GAD, and PMDD and on special populations (i.e., elderly, adolescent). These should not be incorporated into a promotional Paxil PsychNet talk. The speakers have been informed that in accordance with FDA regulations, these slides are only to be used in response to a specific question during the Q&A period of the talk.
Each of your RMAs and PsychNet Regional Contacts have copies of the slide kit presentations. They will not be available for consultants to order on Powerline.
Compensation and Payment

For every PsychNet presentation, the PsychNet physician will be paid an enhanced honorarium of $2500. If the PsychNet speaker gives more than one presentation in a day, the PsychNet speaker will be paid $1000 for each successive presentation delivered in that day.

Your health care education budget will be charged the customary $750 (the average cost of a physician speaker honorarium) for that physician and the supplemental honorarium of $1750 will be charged against the marketing budget allotted to your region budget for PsychNet. For a secondary $1000 PsychNet presentation, $500 will be charged to your health care education budget and $500 will be charged to the regional PsychNet budget.
Produced By GSK In Cunningham v. GSK (U.S.D.C, N.D. Ind.)
To ensure that your PsychNet physician gets paid properly and in a timely fashion, you must:
• Write “PsychNet Presentation” in the “NOTES” section of your speaker request form and indicate $2500 for the honorarium.
• Send in your Speaker Request form as quickly as possible, no later than 30 days prior to the speaking engagement.
• Work with the physician to ensure that he/she submits his/her expense form as quickly as possible after the speaking engagement.
Management of this process will be quicker and easier once the Regional Meeting Planners have been established.
How PsychNet Works:
• There are a total of 65 PsychNet speakers available to speak at engagements nationwide.
• Each speaker has agreed to do a minimum of 4 and no more than 15 talks per year. A final number of talks depends on scheduling and
SB’s regional need.
• PsychNet speakers have signed a confidentiality agreement to not disclose or share information about the PsychNet program, including compensation and content of materials.
• Speakers will be available to begin speaking engagements after the March 10-12trainingmeeting.
• Each region has a limited number of PsychNet talks that will be managed by the RBA or someone designated by your RVP This person will notify all Paxil consultants in the region if the number of PsychNet talks has been or is close to being completely utilized. (Consult your PsychNet Regional Contact to confirm who will manage the PsychNet budget and number of talks in your region.}
NOTE: Once Regional Meeting Planners (RMPs) have been established and set up in your region, they will be in charge of managing the number of PsychNet talks that are available. It is important to consult with them as they have the information on how many talks the region can support financially.
Produced By GSK In Cunningham v. GSK (U.S.D.C, N.D. Ind.) PAR041026960
The Process: How to Begin
1. The consultant should notify his/her PsychNet Regional Contact that he/she is interested in using a PsychNet speaker and make sure that the region is able to support the PsychNet engagement.
2. The consultant should contact the selected speakers to confirm a date for the presentation.
3. Before the program, the consultant and speaker discuss the objectives of the program and select the appropriate presentation.
4. The consultant should provide the PsychNet Regional Contact with the name of the PsychNet speaker and date of the presentation. Copies of the physician’s Curriculum Vitae and hotel/travel and food preferences will be available for your review from the PsychNet Regional Contact.
NOTE: The Regional Meeting Planners will have this responsibility once they are established for the region.
5. The consultant or RMP will coordinate all travel and accommodations for the speaker, arrange the location and manage the invitation process.
6. After the program, the consultant should provide feedback to the Regional Contact on each program.
Questions and Answers
1. One of my PsychNet doctors also gives Hidden Diagnosis talks. Does he receive a $2500 honorarium for a Hidden Diagnosis talk?
No. PsychNet physicians only receive $2500 for a PsychNet speaking engagement: a promotional Pax/7 talk based on one of the PsychNet presentations. It is against CME regulations for SmithKline Beecham or any pharmaceutical company to enhance the honorarium for any CME-related talk. In addition, it is important to realize that the PsychNet honorarium payment is based on the speaker delivering a promotional Paxil presentation, which CME should not be.
2. Does $2500 include travel and dinner expenses?
No. As with normal speaker engagements, speaker travel and dinner expenses come from your health education and/or field funds.
Produced By GSK In Cunningham v. GSK (U.S.D.C., N.D. Ind.)
Produced By GSK In Cunningham v. GSK (U.S.D.C., N.D. Ind.)
P AR041026962
3. Do I have to use only the PsychNet speakers from my region or can I use PsychNet speakers in other regions?
You can use PsychNet speakers from any region. Note, however, that each region has a certain number of speaking engagements that they can fund. It is important to keep your PsychNet Regional Contact informed of the speaker you use and how many engagements you set up in your area.
4. Who do I contact if I have questions about the PsychNet program, a speaker or the content of the slide kits?
All of your RMAs will have a PsychNet slide kit available to them. In addition, there is a DSM or RMA PsychNet contact for each region. He/she is available to answer any questions you may have regarding the PsychNet program. See the back of this booklet for your Regional Contact for PsychNet
5. My speaker has already done 9 presentations and he wants to do more, but our region has no more money available to support his honorarium. Can we make an exception?
No. Each region has been allocated a set number of funds for this program that is fixed. We cannot exceed this budget for 2000.
While we strongly encourage the use of PsychNet speakers as many times as possible, you should not feel obligated to offer each
PsychNet physician 15 speaking engagements if that is not necessary for your region. The confidentiality agreement clearly states that only “a minimum of 4 up to 15. The number of presentations will be determined by scheduling and SB’s regional need.”
6. How will the program work when the Regional Meeting Planner is appointed to our region?
In terms of coordination, PsychNet will operate the same way most speaker programs will. Your RMP will coordinate the travel and accommodations for the speaker, send out invitations, and set up the meeting, and disburse payment. In addition, the RMP will monitor the number of PsychNet talks done in the region.
7. Can I order a copy of the slide presentations and distribute them to other speakers that are not a part of the PsychNet Council?
No. PsychNet slide kits are not available at this time for consultant use, nor are we distributing them to physicians not a part of the PsychNet Council. If it is necessary for you to review the presentations, contact your RMA or the PsychNet Regional Contact.
8.1 know a PsychNet physician that could not make the March 10-12 weekend training session. Can I still have him speak?
Yes, but only after he has been trained. All PsychNet physicians that could not make the training meeting will be trained by the Regional Contact at a later date. Please contact your Regional Contact to obtain the date after which the PsychNet speaker will be trained and available to make PsychNet engagements.
9. Why should I use a PsychNet physician rather than any other physician?
There are many advantages for using a PsychNet speaker: • They have been educated on the positive data for Paxil in depression,
social anxiety disorder, OCD and panic disorder.
• Regardless of the cost of a speakers regular honorarium, you pay only $750 from your budget to grant the speaker an enhanced honoraria of$2500.
• You help build Paxil advocacy from the PsychNet key opinion leader. PsychNetls an ideal way for key opinion leaders to influence clinicians
in your region on the benefits of PaxilVersus competitors.
Produced By GSK In Cunningham v. GSK (U.S.D.C., N.D. Ind.)
Produced By GSK In Cunningham v. GSK (U.S.D.C, N.D. Ind.)
P AR041026964
Regional Contact List
New England Shore Region
Northern Lights PA/West Virginia Desert Mountain Mid-America Pacific Sun South Central South West Empire State Pacific Northwest River Valley Florida
South East Blue Ridge
John Cosseboom (DSM)
Lee Drosdak (DSM) Mary Sotirhos (RMA)
Marcelo Ferreyra (DSM) Jim Glavin (RMA) Cindy McKinney (DSM) Sheri Mullen (DSM) Judy Parsons (DSM) Norm H. Rutz (DSM) Karen Schaefer (RMA) Laura Shostak (RMA) Andrew Smith (RMA) Sheldon Thomas (DSM) John Weiner (RMA) Chris Wilkinson (DSM) Sonny Woodruff (DSM)
3128357 3433406
5124783 3341971 1625779 1326845 5427735 1411120 1543107 3243971 5744045 3540814 1127791 3621087 1210239
Beatriz Currier, MD Department of Psychiatry University of Miami 1611 NW12 Avenue Miami, FL 33125 Phone: 305 585 6115
Joseph Henry, MD 1400 NW 10th Avenue Room 304-A Miami, FL 33136 Phone: 305 243 4060 Fax: 954 437 7654
David Sheehan, MD, MBA 3315 E. Fletcher Avenue University of South Florida College of Medicine Department of Psychiatry 3rd Floor
Tampa, FL 33613 Phone: 813 974 4544 FAX: 813 974 4575
Emil Coccaro, MD University of Chicago 5841 South Maryland Avenue Chicago, IL 60637 Phone: 773 834 2660
Moises Gaviria, MD 912 Wood Street Chicago, IL 60612 Phone:312996 6139 Fax: 312 9961587
Bennett Leventhal, MD University of Chicago 5841 South Maryland Avenue Chicago, IL 60637 Phone: 773 702 6751
Anatha Shekhar, MD IU Medical Center 550 University Boulevard 3rd Floor Indianapolis, IN 46202
In Cunningham v. GSK (U.S.D.C, N.D. Ind.)
Produced By GSK In Cunningham v. GSK (U.S.D.C, N.D. Ind.)
n.-~,j..~~,j D., r^ois i—r^. .„„;„„u-,^, ., ^oiy /i i o r~vr* M r^i I~,J \ n Ar-»/i>iA r\r\r.r\/^-?
Beatriz Currier, MD Department of Psychiatry University of Miami 1611 NW 12 Avenue Miami, FL 33125 Phone: 305 585 6115
Joseph Henry, MD 1400 NW 10th Avenue Room 304-A Miami, FL 33136 Phone: 305 243 4060 Fax: 954 437 7654
David Sheehan, MD, MBA 3315 E.Fletcher Avenue University of South Florida College of Medicine Department of Psychiatry 3rd Floor
Tampa, FL 33613 Phone: 813 974 4544 FAX: 813 974 4575
Michael Ware, MD 2831 NW 41 Street Gainesville, FL 32606 Phone:352 3731332
Guy Brannon, MD 1002 Highland Avenue Shreveport,LA71101 Phone: 215 413 7892
Ross Gallow, MD 824 Elmwood Park Suite 135 New Orleans, LA 70123 Phone: 215 413 7892
David L Snow, MD Associate Medical Director Emotional Health & Recovery
Center Blount Memorial Hospital 659 Morganton Square Drive MaryvilleJN 37801 Phone: 865 984 9933 Fax: 865 982 9428
University of Chicago 5841 South Maryland Avenue Chicago, IL 60637 Phone: 773 834 2660
Moises Gaviria, MD 912 Wood Street Chicago, IL 60612 Phone: 312996 6139 Fax: 312 996 1587
Bennett Leventhal, MD University of Chicago 5841 South Maryland Avenue Chicago, IL 60637 Phone: 773 702 6751
Anatha Shekhar, MD IU Medical Center 550 University Boulevard 3rd floor
Indianapolis, IN 46202 Phone: 317 2741246
John Zajecka, MD 1725 Harrison #955 Chicago, IL 60612 Phone: 312 942 4000
Dale Anderson, MD 1035 Bellvue Suite 412 St. Louis, MO 63117 Phone: 314 645 1567
Donald Chesler, MD 1000 North Lee Oklahoma City, OK 73101 Phone: 405 272 6716
Ray Clark, MD 5 St. Vincent Circle Suite 301 Little Rock, AR 72205 Phone: 501 666 4266 Fax: 501 666 2149
Jerold J. Kreisman, MD 12255 DePaul Drive Suite 500 Bridgeton, MO 63044 Phone: 314 3447575 Fax: 314 344 7571
Produced By GSK In Cunningham v. GSK (U.S.D.C, N.D. Ind.)
H. Mykel Thomas, MD 5701 West 119th, #407 Overland Park, KS 66209 Phone: 913 323 3801
Stephen Kyle Brannan, MD Department of Psychiatry UTHSCSA 7703 Floyd Curl Drive
San Antonio, TX 78284 Phone: 210 567 5450 Fax: 210 567 6941
Doyle Carson, MD 777 Walter Reed Boulevard Suite 305 Garland, TX 75042 Phone: 972 276 0755 Fax: 972 494 3062
Mary Ann Ty, MD 7324 SW Freeway Suite 610 Houston, TX 77074 Phone: 713 7798963 Fax: 713 777 8963
Jean-Joseph Vanderpool, MD 6151 Dew Drive El Paso, TX 79912 Phone: 915 833 5855
Nishendu Vasavada, MD 560 West Main Suite 101 Lewisville, TX 75057 Phone: 972 2211741
Alvin Burstein, MD 2701 Camelback Suite 203 Phoenix, AZ 85016 Phone: 602 957 2368
Robert Davies, MD 4200 East 9th Avenue Denver, CO 80262 Phone: 303 3150452
Steve Methner, MD 501 South Chipeta Way Salt Lake City, UT 84108 Phone: 801 584 2098
Neil Weiner, MD 4770 East lliff Avenue Suite 229 Denver, CO 80222 Phone:303 756 4608
Robert Winski, MD 2033 East Speedway Boulevard Tucson, AZ 85719 Phone: 520 319 3607
Chalakudy Ramakrishna, MD 15645 Farmington Road Livonia, Ml 48154 Phone: 734 422 4748
Jeffrey Simon, MD 9275 North 49th Street Suite 200 Brown Deer, Wl 53223 Phone: 414 357 9444 Fax: 414 357 9422
ReidTaylor, DO 720 Goldenrod Avenue Holland, Ml 49423 Phone: 616 847 5145 Fax: 616 8421495
Scott Yarosh.MD 2550 University Avenue West Suite 229N St Paul, MN 55114 Phone: 651 6453115 Fax: 651 645 2752
Robert Hales, MD 2230 Stockton Boulevard Sacramento, CA 95817 Phone:916734 2980
Allen K. Louie, MD UCSF/Langley Porter
Psychiatric Institute 401 Parnassus Avenue Box F Room 367 San Francisco, CA 95143 Phone: 415 4767017
Michael Resnick, MD 3491 Northwest Raleigh Portland, OR 97210 Phone: 503 784 8539
Produced By GSK In Cunningham v. GSK (U.S.D.C, N.D. Ind.)
Dane Wingerson, MD 325 9th Avenue Box 359896 Seattle, WA 98104 Phone: 206 731 3425
UCLA Neuropsychiatric Institute 760 Westwood Plaza Los Angeles, CA 90024 Phone: 310 206 5135
Amir Kalali, MD Quintiles 10201 Waterridge Circle San Diego, CA 92121 Phone: 858 646 2541
Sidney Zisook, MD Department of Psychiatry 9500 Gilman Drive La Jolla, CA 92093 Phone: 858 534 4040 Fax: 858 552 8585
Amjad Bahnassi, MD 198 Russell Street Worcester, MA 01609 Phone: 508 753 5554 Fax: 508 752 7245
Robert J. Birnbaum, MD One Deaconess Road Boston, MA 02115 Phone: 617 632 0100
Michael E. Hirsch, MD Associate Director of
Psychopharmacology Department of Psychiatry One Deaconess Road First Floor Boston, MA 02215 Phone: 617 632 0103 Fax: 617 632 7721
Craig Nelson, MD Professor of Psychiatry Director of Inpatient Services
Yale University School of Medicine
333 Cedar Street New Haven, CT 06520 Phone: 203 688 2157
Mark Pollack, MD 15 Parman Street Boston, MA 02114 Phone: 617 726 3488
George Alexpoloulos, MD 22 Bloomingdale Road White Plains, NY 10605 Phone: 914 997 5767
Jeremy Copeland, MD 75-59 263rd Street Glen Oaks, NY 11005 Phone: 718 470 8000

‘/… .• ar i ;vv.’
Manuel B. Montes De Oca, MD 22 Mountainview Avenue Suffern, NY 10901 Phone: 914 368 4384
Robert Weisman, DO 165Q Elmwood Rochester, NY 14620 Phone: 716 275 0300
Richard Wolin, MD 295 Essjay Avenue Williamsville, NY 14221 Phone: 716 630 1204
PENNSYLVANIA/WEST VIRGINIA REGION (RC) M. Khalid Hasan, MD Raleigh Psychiatric Services
24 Mallard Court BeckleyWV 25801 Phone: 304 252 8409 Fax: 304 252 0022
Produced By GSK In Cunningham v. GSK (U.S.D.C, N.D. Ind.)
Stuart Levy, DO Friends Hospital 4641 Roosevelt Boulevard Philadelphia, PA 19124 Phone: 215 330 8760 Fax: 215 831 6998
Kenneth B. Nelson, MD Valley Forge Mental Hospital 1033 Germantown Pike Norristown, PA 19401 Phone: 610 539 8500
Rajendra Nigam, MD Western Pennsylvania
PsychCare 150 Pleasant Drive Suite G-5 Aliquippa, PA 15001 Phone: 724 3751050
Martin Buxton, MD 7001 Jahnke Road Richmond, VA 23225 Phone: 804 323 4282
Michael Glasser, MD 9055 Shady Grove Court Gaithersburg, MD 20877 Phone: 301330 0400
Arnold Goldman, MD 401 Kings Highway South Cherry Hill, NJ 08034 Phone: 856 216 0505
Geetha Jayarem, MD 4009 Wildwood Way Ellicott City, MD 21042 Phone: 410461 1058 Fax: 410 4611058
Matthew Pitera, MD Psychiatric Associates Hackensack University Medical
Center 20 Prospect Avenue, Suite 712 Hackensack, New Jersey 07601 Phone: 201488 6543



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s